| . | No. . | Age (years ± SEM) . | Sex Ratio (M:F) . | Current Medication (no.) . | Antibiotic Treatment . |
|---|---|---|---|---|---|
| Healthy Controls | n = 7 | 33 ± 2.2 | 2.5 | None | No |
| Crohn’s Disease | n = 13 | 49 ± 4.1 | 1.4 | Immunotherapy (6) Steroids or mesalamine (3) Others (1) | No |
| Ulcerative Colitis | n = 11 | 40 ± 4.0 | 1.8 | Immunotherapy (1) Mesalamine (3) Others (1) | No |
| . | No. . | Age (years ± SEM) . | Sex Ratio (M:F) . | Current Medication (no.) . | Antibiotic Treatment . |
|---|---|---|---|---|---|
| Healthy Controls | n = 7 | 33 ± 2.2 | 2.5 | None | No |
| Crohn’s Disease | n = 13 | 49 ± 4.1 | 1.4 | Immunotherapy (6) Steroids or mesalamine (3) Others (1) | No |
| Ulcerative Colitis | n = 11 | 40 ± 4.0 | 1.8 | Immunotherapy (1) Mesalamine (3) Others (1) | No |
Values are total number of patients (n). F, female; M, male; SEM, standard error of mean.
| . | No. . | Age (years ± SEM) . | Sex Ratio (M:F) . | Current Medication (no.) . | Antibiotic Treatment . |
|---|---|---|---|---|---|
| Healthy Controls | n = 7 | 33 ± 2.2 | 2.5 | None | No |
| Crohn’s Disease | n = 13 | 49 ± 4.1 | 1.4 | Immunotherapy (6) Steroids or mesalamine (3) Others (1) | No |
| Ulcerative Colitis | n = 11 | 40 ± 4.0 | 1.8 | Immunotherapy (1) Mesalamine (3) Others (1) | No |
| . | No. . | Age (years ± SEM) . | Sex Ratio (M:F) . | Current Medication (no.) . | Antibiotic Treatment . |
|---|---|---|---|---|---|
| Healthy Controls | n = 7 | 33 ± 2.2 | 2.5 | None | No |
| Crohn’s Disease | n = 13 | 49 ± 4.1 | 1.4 | Immunotherapy (6) Steroids or mesalamine (3) Others (1) | No |
| Ulcerative Colitis | n = 11 | 40 ± 4.0 | 1.8 | Immunotherapy (1) Mesalamine (3) Others (1) | No |
Values are total number of patients (n). F, female; M, male; SEM, standard error of mean.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
